Saniona utser Wendy Dwyer till Chief Business Officer

NEXT STORY
atai Life Sciences Increases Loan in Principal by US$6m to Support IntelGenx’s Graduation to Toronto Stock Exchange After Positive Early Feasibility Study Data
PREV STORY
Revolution Medicines to Participate in 3rd Annual RAS-Targeted Drug Development Summit
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cellceutix Reports 24 Core Phase 2b Clinical Trial Sites for Oral Prurisol Treatment of Moderate-To-Severe Psoriasis Initiated and Open for Screening

BEVERLY, Mass., Dec. 19, 2016 (GLOBE NEWSWIRE) -- Cellceutix Corporation (OTCQB:CTIX) (“the Company”), a ...

author_avatar
NASDAQ Market News

Novartis survey uncovers real-world impact of immune thrombocytopenia or ITP, a rare blood disease, on patients’ quality of life

Findings from more than 1,300 patients across 13 countries showed ITP had especially high ...

author_avatar
NASDAQ Market News

DBV Technologies Shows Commitment to the Development of Treatments for Food Allergies at EAACI 2018

Montrouge, France, May 29, 2018 DBV Technologies Shows Commitment to the Development of Treatments ...

author_avatar
NASDAQ Market News